51 – 60 of 139
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
New antimicrobial cystatin C-based peptide active against gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci
(2003) In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 111(11). p.1004-1010
- Contribution to journal › Article
- 2001
-
Mark
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
- Contribution to journal › Article
- 1999
-
Mark
Cystatin C deficiency in human atherosclerosis and aortic aneurysms
- Contribution to journal › Article
- 1998
-
Mark
Affinity screening for weak monoclonal antibodies
- Contribution to journal › Article
-
Mark
The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C
- Contribution to journal › Article
-
Mark
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
- Contribution to journal › Article
-
Mark
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration
- Contribution to journal › Article
-
Mark
Serum cystatin C as a determinant of glomerular filtration rate in children
- Contribution to journal › Article
-
Mark
Screening for weak monoclonal antibodies in hybridoma technology
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1997
-
Mark
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes
- Contribution to journal › Article
